Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA in a Shutdown: The Plan Still Matters

This article was originally published in RPM Report

Executive Summary

A government shutdown was averted but not until federal agency’s were forced to communicate their shutdown plans to employees and the public. Those plans may have a lingering impact—and not just because the threat of a shutdown is sure to arise again.

You may also be interested in...



FDA’s Shutdown Plan: Some User Fee Services Would Continue; Routine Inspections Would Not

The agency would retain 8,180 staff members, about 55% of its total, mostly because they could be “paid from carryover funding.”

FDA Leadership Changes Reflect Budgetary, Scientific Challenges

FDA has a new chief operating officer and medical officer. The appointments reflect the challenges of a lean budget and calls for a chief scientist from the Institute of Medicine.

PDUFA IV: You Can't Always Get What You Want

Former Senate HELP Committee FDA counsel Steven Irizarry looks ahead at the reauthorization of PDUFA and what drug companies should expect in the latest round of negotiations.

Related Content

Topics

UsernamePublicRestriction

Register

PS080820

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel